Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02393534 · ClinicalTrials.gov registry record · Phase 4
Feasibility of Telephone Follow-up Visits in Primary Care
A Phase 4 study of No Specific Condition, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT02393534: Completed Phase 4 study of No Specific Condition, sponsored by NYU Langone Health.
NCT02393534 is a Phase 4 study of No Specific Condition that has completed, run by NYU Langone Health. The registered enrollment target is 11 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02393534, a Phase 4 study of No Specific Condition, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
Doctors frequently speak with their patients over the telephone. Having a visit with a doctor over the telephone rather than face-to-face can be convenient for patients and allow them to save time and money on transportation and missed time from work. However, some patients may prefer seeing the doctor in person. In this study, we will study two groups of patients - some who have their visits with their doctor over the telephone and some who have them face-to-face. Using surveys and interviews, we will study if the groups differ in their satisfaction with their visit with their doctor after participating in the study for 6 months. We will also look at doctor satisfaction with telephone visits, use of clinic resources and if patients received recommended care such as laboratory tests and vaccines during the study period.
Primary Outcome
Proportion of patients recruited out of the total population and proportion of patients retained at 6 months.
Conditions Studied
Interventions
- OTHER Telephone Visit
Study Locations (1)
New York
- Gouverneur TDC - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
What the finished NCT02393534 record still lists
NCT02393534 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 1 condition, with No Specific Condition appearing as the primary indexed condition, and to 1 intervention - of which Telephone Visit is the first listed.
NCT02393534 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02393534 about?
NCT02393534 is a clinical study titled "Feasibility of Telephone Follow-up Visits in Primary Care". Doctors frequently speak with their patients over the telephone. Having a visit with a doctor over the telephone rather than face-to-face can be convenient for patients and allow them to save time and money on transportation and missed time from work. However, some patients may prefer seeing the doc...
What is the current status of trial NCT02393534?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2015-06. Estimated completion is 2016-04.
What conditions does trial NCT02393534 study?
This clinical trial studies the following conditions: No Specific Condition.
What interventions are being tested in trial NCT02393534?
The interventions under investigation include: Telephone Visit (OTHER).
Who is sponsoring clinical trial NCT02393534?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02393534 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02393534's enrollment target sits among peer trials
11 1932nd of 2000 higher than 61 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia